Myocarditis following COVID-19 mRNA vaccination-Reference-Cited by-同舟云学术

Myocarditis following COVID-19 mRNA vaccination

Published:2021-06 Issue:29 Volume:39 Page:3790-3793
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Abu Mouch Saif,Roguin Ariel^ORCID,Hellou Elias^ORCID,Ishai Amorina,Shoshan Uri,Mahamid Lamis,Zoabi Marwan,Aisman Marina,Goldschmid Nimrod,Berar Yanay Noa

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

2. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates;Walsh;N Engl J Med,2020

3. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020;Oliver;MMWR Morb Mortal Wkly Rep,2020

4. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations;Ferreira;J Am Coll Cardiol,2018

5. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management;Siripanthong;Heart Rhythm,2020

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center;Vaccine;2024-10

2. Occurrence of Myopericarditis Following COVID-19 Vaccination Among Adults in the Eastern Region, Saudi Arabia: A Multicenter Study;International Journal of General Medicine;2024-07

3. Incidence of neurological complication symptoms post-mRNA vaccination among the urban population of Makkah Province of Kingdom of Saudi Arabia;Vacunas (English Edition);2024-07

4. Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial;Vaccines;2024-06-19

5. New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy;Heart Failure Reviews;2024-06-19